Pediatric dermatology
Assessment of Growth Hormone and Insulin-Like Growth Factor 1 in Children With Epidermolysis Bullosa Dystrophica.
Mohammad El Darouti, Iman Sany Zaki, Noha Mousa, Hagar El Sayed
Published: 202510.1111/pde.70113
Abstract
BACKGROUND: Epidermolysis bullosa dystrophica (EBD) is characterized by mucocutaneous fragility with blistering, scarring and severe growth retardation attributed to many factors. METHODS: This cross-sectional study included 51 patients aged 1-12 yea…
Preview only. Read the full abstract at the source